Lauren Spoo, MD
Obstetrics & Gynecology · Houston, TXNPI 1457708075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,162 and has fallen 82.3% since, to $206 in 2025.
Across 158 payments — averaging $22.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$453
- Mayne Pharma Commercial LLC$432
- AbbVie$362
- Exeltis, USA Inc.$262
- Evofem Biosciences, Inc.$221
- Pfizer$178
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,489100%
- Entertainment$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $453 |
| Mayne Pharma Commercial LLC | 18 | $432 |
| AbbVie | 20 | $362 |
| Exeltis, USA Inc. | 16 | $262 |
| Evofem Biosciences, Inc. | 12 | $221 |
| Pfizer | 11 | $178 |
| Sumitomo Pharma America, Inc. | 5 | $131 |
| Astellas Pharma US Inc | 6 | $127 |
| KCI USA, Inc. | 1 | $123 |
| Organon | 6 | $118 |
| Amgen | 2 | $115 |
| Therapeuticsmd, Inc. | 7 | $112 |
| Ascend Therapeutics US, LLC | 5 | $107 |
| Bayer | 3 | $83 |
| Merck | 4 | $71 |
| Shield Therapeutics Inc | 4 | $61 |
| Millicent US Inc | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 2 | $46 |
| Avion Pharmaceuticals | 2 | $43 |
| Myovant Sciences Inc. | 2 | $42 |
| Gynesonics, Inc. | 2 | $35 |
| Johnson & Johnson | 1 | $34 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Scynexis, Inc. | 2 | $28 |
| Medtronic | 1 | $25 |
| Exact Sciences | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Myriad Women's Health, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $19 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Cosette Pharmaceuticals Inc. | 1 | $18 |
| Medicem Inc. | 1 | $17 |
| Argentum Medical | 1 | $14 |
| Minerva Surgical, Inc | 1 | $12 |
| Agile Therapeutics, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$225
- PREVENA$123
- VAC VERAFLO$123
- Wegovy$116
How this compares
$3,503 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 59 | $5,278 |
| Estradiol | 57 | $4,161 |
| ProgesteroneProgesterone, Micronized | 51 | $2,047 |
| Clobetasol Propionate | 11 | $236 |
| Triamcinolone Acetonide | 12 | $136 |
| Fluconazole | 18 | $44 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Houston
- George KuhnHouston$244K
- Daisy AyimHouston$188K
- Shannon WestinHouston$176K
- Asha BhalwalHouston$151K
- Nicole TranHouston$133K
- Sandra HurtadoHouston$123K
- Alvaro MontealegreHouston$92K
- Patti RossHouston$72K
- Damla KarsanHouston$58K
- Christopher JayneHouston$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.